New Hep C Treatment Can Cure Most Patients

hepatitis C without interferon, with cure rates often exceeding 95%, according to a recently published review. "Oral DAA regimens that are highly efficacious, well-tolerated, and relatively short in duration are now available for all [hepatitis C virus] genotypes and for patient populations historically considered difficult to cure," wrote Oluwaseun Falade-Nwulia, MBBS, MPH, from Johns Hopkins School of Medicine in Baltimore and co-authors. The systematic review, which looked at 42 studies of DAAs used in interferon-free regimens, is published online in the Annals of Internal Medicine. "There are now several highly effective and well-tolerated regimens that can be used to produce cure of hepatitis C in a wide range of chronically infected persons," Raymond Chung, MD, chief of hepatology at Massachusetts General Hospital in Boston, told MedPage Today. https://www.medpagetoday.com/reading-room/aga/lower-gi/64857?xid=nl_mpt_DHE_2017-04-28&eun=g721819d0r&pos=2